GPT and chronic kidney disease: Gender, age, BMI, systolic and diastolic BP with hypertension history, heart rate, smoking, drinking, CAD, hyperlipidemia with higher triglyceride and cholesterol levels (missing 2.67%), stroke, DM with abnormal glucose control (hbA1c missing 5.67%) and therapy, CKD history with lower eGFR (missing 0.67%), and alanine transaminase (ALT) (missing 0.67%) did not differ significantly among patients in the three Phe groups (P > 0.05).